2026 NPPES data Hematology & Oncology Physician NPI 1255821617 MD
Verify on CMS →

Rachel Abelman, MD

Hematology & Oncology Physician in Boston, Massachusetts.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
92
Medicare Part D claims · 23 beneficiaries · Hematology & Oncology Physician avg: 847
Industry payments
$179.02
4 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Rachel Abelman, MD filed 92 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Boston, Massachusetts.

92
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Rachel Abelman, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

92 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Rachel Abelman, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Rachel Abelman, MD?

Quality data not reported

NPI registry status

Active

Issued 05/11/2018

NPI 1255821617

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

92 89% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Massachusetts

How Hematology & Oncology Physician compares to other specialties among Massachusetts providers

Massachusetts providers
Mental Health Counselor - 8.3%Mental Health Counselor8.3%Clinical Social Worker - 7.8%Clinical Social Worker7.8%Student in an Organized Health Care Education/Training Program - 6.2%Student in an Organized Health Care Education/Training Program6.2%Behavior Technician - 4.9%Behavior Technician4.9%Counselor - 4.3%Counselor4.3%Internal Medicine Physician - 3.7%Internal Medicine Physician3.7%Hematology & Oncology Physician - 0.2%Hematology & Oncology Physician0.2%
Largest specialties in Massachusetts (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Rachel Abelman, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 55 FRUIT ST, Boston, MA, 02114, with a listed phone of (617) 231-9943. NPI 1255821617 was issued on 05/11/2018.

Medicare Part D records for calendar year 2023 show 92 prescription claims written by this provider, covering 23 Medicare beneficiaries and totaling roughly $81K in drug spend.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

55 FRUIT ST
Boston, MA 02114

Provider Details

NPI 1255821617
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 05/11/2018

Hospital and facility affiliations

Facilities where Rachel Abelman, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Massachusetts General Physicians Organization Inc
Boston, MA
The General Hospital Corporation
Boston, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rachel Abelman, MD. Source: openpaymentsdata.cms.gov.

Total received

$179

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Massachusetts BORIM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Rachel Abelman, MD. To verify Rachel Abelman, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

92
Total Claims
$81K
Total Drug Cost
23
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
149
Total Day Supply
3,823
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
2.04

Hematology & Oncology Physician Overview

How Rachel Abelman, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Rachel Abelman, MD's 92 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Abelman.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Rachel Abelman, MD's specialty?
Rachel Abelman, MD specializes in Hematology & Oncology Physician and practices in Boston, Massachusetts. Credentials: MD.
How much does Rachel Abelman, MD prescribe under Medicare Part D?
In 2023, Rachel Abelman, MD wrote 92 Medicare Part D claims totaling $81K in drug costs for 23 beneficiaries.
Where is Rachel Abelman, MD located?
Rachel Abelman, MD is located at 55 FRUIT ST, Boston, MA, 02114. Phone: (617) 231-9943.
What is Rachel Abelman, MD's NPI number?
Rachel Abelman, MD's National Provider Identifier (NPI) is 1255821617, issued on 05/11/2018.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
Does Rachel Abelman, MD accept Medicare?
Rachel Abelman, MD appears in CMS Medicare data with 92 Part D claims and 23 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rachel Abelman, MD's credentials?
Rachel Abelman, MD's NPI is 1255821617 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.